Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model

Peptides

Volumn 31, Issue 11, 2010, Pages 2135-2140

  Bedini, Andrea ^a   Baiula, Monica ^a   Gentilucci, Luca ^a   Tolomelli, Alessandra ^a   De Marco, Rossella ^a   Spampinato, Santi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antinociception; Endomorphin 1; mu Opioid receptor; Naloxone methiodide; Visceral pain

Indexed keywords

17 METHYLNALOXONE; ACETIC ACID; BETA FUNALTREXAMINE; CYCLOPEPTIDE; ENDOMORPHIN 1; MU OPIATE RECEPTOR AGONIST; NALOXONAZINE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENZYMATIC DEGRADATION; HYDROLYSIS; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; VISCERAL PAIN; WRITHING TEST;

ANALGESICS; ANIMALS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN; PEPTIDES, CYCLIC; RECEPTORS, OPIOID, MU;

EID: 77957830877     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.08.005     Document Type: Article

References (40)

1. W.A. Banks Characteristics of compounds that cross the blood-brain barrier BMC Neurol 9 Suppl. 1 2009 S3
2. A. Brack, H.L. Rittner, H. Machelska, K. Leder, S.A. Mousa, and M. Schäfer Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells Pain 112 2004 229 238 (Pubitemid 39550722)
3. J.H. Broadbear, S.S. Negus, E.R. Butelman, B.R. de Costa, and J.H. Woods Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay Psychopharmacology 115 1994 311 319
4. P.S. Burton, R.A. Conradi, N.F. Ho, A.R. Hilgers, and R.T. Borchardt How structural features influence the biomembrane permeability of peptides J Pharm Sci 85 1996 1336 1340
5. G. Cardillo, L. Gentilucci, A.R. Qasem, F. Sgarzi, and S. Spampinato Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance J Med Chem 45 2002 2571 2578
6. G. Cardillo, L. Gentilucci, A. Tolomelli, R. Spinosa, M. Calienni, and A.R. Qasem Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-] J Med Chem 47 2004 5198 5203
7. H.O.J. Collier, L.C. Dinneen, A. Chistine, A. Johnson, and C. Schneider The abdominal constriction response and its suppression by analgesic drugs in the mouse Br J Pharmacol Chemother 32 1968 295 310
8. T.J. Coderre Potent analgesia induced in rats by combined action at PCP and polyamine recognition sites of the NMDA receptor complex Eur J Neurosci 5 1993 390 393
9. R.M. Craft, S.R. Henley, R.C. Haaseth, V.J. Hruby, and F. Porreca Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration J Pharmacol Exp Ther 275 1995 1535 1542
10. J. Fichna, A. Janecka, J. Costentin, and J.C. Do Rego The endomorphin system and its evolving neurophysiological role Pharmacol Rev 59 2007 88 123
11. V. Ganapathy, and S. Miyauchi Transport systems for opioid peptides in mammalian tissues AAPS J 7 2005 E852 E856
12. G.F. Gebhart, X. Su, S. Joshi, N. Ozaki, and J.N. Sengupta Peripheral opioid modulation of visceral pain Ann N Y Acad Sci 909 2000 41 50
13. L. Gentilucci, F. Squassabia, R. Demarco, R. Artali, G. Cardillo, and A. Tolomelli Investigation of the interaction between the atypical agonist c[YpwFG] and MOR FEBS J 275 2008 2315 2337
14. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br J Pharmacol 12 1957 12 15
15. D.S. Jessop, L.J. Richards, and M.S. Harbuz Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation Ann N Y Acad Sci 966 2002 456 463
16. A.J. Kastin, M.B. Fasold, R.R. Smith, K.A. Horner, and J.E. Zadina Saturable brain-to-blood transport of endomorphins Exp Brain Res 139 2001 70 75
17. Y.A. Kolesnikov, I. Chereshnev, and G.W. Pasternak Analgesic synergy between topical lidocaine and topical opioids J Pharmacol Exp Ther 295 2000 546 551
18. D. Labuz, S. Berger, S.A. Mousa, C. Zöllner, H.L. Rittner, and M.A. Shaqura Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain J Neurosci 26 2006 4350 4358
19. D. Labuz, S.A. Mousa, M. Schäfer, C. Stein, and H. Machelska Relative contribution of peripheral versus central opioid receptors to antinociception Brain Res 1160 2007 30 38
20. T. Lewanowitsch, and R.J. Irvine Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal Eur J Pharmacol 445 2002 61 67
21. Z.H. Li, L.D. Shan, X.H. Jiang, S.Y. Guo, G.D. Yu, and T. Hisamitsu Analgesic effect of endomorphin-1 Acta Pharmacol Sin 22 2001 976 980
22. H. Machelska, A. Brack, S.A. Mousa, J.K. Schopohl, H.L. Rittner, and M. Schäfer Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain Br J Pharmacol 142 2004 772 780
23. S.A. Mousa, H. Machelska, M. Schäfer, and C. Stein Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain J Neuroimmunol 126 2002 5 15
24. G.W. Pasternak, and P.J. Wood Multiple mu opiate receptors Life Sci 38 1986 1889 1898
25. C.G. Pick, D. Paul, and G.W. Pasternak Comparison of naloxonazine and beta funaltrexamine antagonism of mu 1 and mu 2 opioid actions Life Sci 48 1991 2005 2011
26. T.L. Pierce, and M.W. Wessendorf Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain J Chem Neuroanat 18 2000 181 207
27. R.C. Polomano, J.P. Rathmell, D.A. Krenzischek, and C.J. Dunwoody Emerging trends and new approaches to acute pain management Pain Manag Nurs 9 1 Suppl. 2008 S33 41
28. R. Przewlocki, and B. Przewlocka Opioids in chronic pain Eur J Pharmacol 429 2001 79 91
29. J.A. Reichert, R.S. Daughters, R. Rivard, and D.A. Simone Peripheral and preemptive opioid antinociception in a mouse visceral pain model Pain 89 2001 221 227
30. S. Sakurada, T. Hayashi, M. Yuhki, T. Fujimura, K. Murayama, and A. Yonezawa Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone Peptides 23 5 2002 895 901
31. S. Sakurada, J.E. Zadina, A.J. Kastin, S. Katsuyama, T. Fujimura, and K. Murayama Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception Eur J Pharmacol 372 1999 25 30
32. M. Schreff, S. Schulz, D. Wiborny, and V. Hollt Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord Neuroreport 9 1998 1031 1034
33. Z.H. Song, and A.E. Takemori Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice J Pharmacol Exp Ther 254 1990 363 368
34. S. Spampinato, A.R. Qasem, M. Calienni, G. Murari, L. Gentilucci, and A. Tolomelli Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline Eur J Pharmacol 469 2003 89 95
35. C. Stein, and L.J. Lang Peripheral mechanisms of opioid analgesia Curr Opin Pharmacol 9 2009 3 8
36. S. Van Dorpe, A. Adriaens, I. Polis, K. Peremans, J. Van Bocxlaer, and B. De Spiegeleer Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides Peptides 31 2010 1390 1399
37. I. van Rooy, S. Cakir-Tascioglu, P.O. Couraud, I.A. Romero, B. Weksler, and G. Storm Identification of peptide ligands for targeting to the blood-brain barrier Pharm Res 27 2010 673 682
38. T.W. Vanderah, T. Largent-Milnes, J. Lai, F. Porreca, R.A. Houghten, and F. Menzaghi Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors Eur J Pharmacol 583 2008 62 72
39. K.A. Witt, and T.P. Davis CNS drug delivery: opioid peptides and the blood-brain barrier AAPS J 8 2006 E76 E88
40. J.E. Zadina, L. Hackler, L.J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the mu-opiate receptor Nature 386 1997 499 502